Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years.

Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years.

Diğer sürümleri göster (1)

Survival has improved in bladder cancer but few studies have considered extended periods or covered populations for which medical care is essentially free of charge. We analyzed survival in urothelial cancer (UC, of which vast majority are bladder cancers) in Finland and Sweden over a 50-year period...

Detaylı Bibliyografya
Asıl Yazarlar:	Kari Hemminki, Asta Försti, Akseli Hemminki, Börje Ljungberg, Otto Hemminki
Materyal Türü:	Makale
Dil:	English
Baskı/Yayın Bilgisi:	Public Library of Science (PLoS) 2022-01-01
Seri Bilgileri:	PLoS ONE
Online Erişim:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0261124&type=printable

Benzer Materyaller

Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years
Yazar:: Kari Hemminki, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden.
Yazar:: Kari Hemminki, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Survival in colon and rectal cancers in Finland and Sweden through 50 years
Yazar:: Akseli Hemminki, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

Incidence trends in bladder and lung cancers between Denmark, Finland and Sweden may implicate oral tobacco (snuff/snus) as a possible risk factor
Yazar:: Kari Hemminki, ve diğerleri
Baskı/Yayın Bilgisi: (2021-05-01)

Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment
Yazar:: Kari Hemminki, ve diğerleri
Baskı/Yayın Bilgisi: (2022-04-01)

Incidence and survival in laryngeal and lung cancers in Finland and Sweden through a half century.
Yazar:: Anni Koskinen, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Bladder and upper urinary tract cancers as first and second primary cancers
Yazar:: Guoqiao Zheng, ve diğerleri
Baskı/Yayın Bilgisi: (2021-12-01)

Critical survival periods in prostate cancer in Sweden explored by conditional survival analysis
Yazar:: Kari Hemminki, ve diğerleri
Baskı/Yayın Bilgisi: (2024-04-01)

Survival, Incidence, and Mortality Trends in Female Cancers in the Nordic Countries
Yazar:: Filip Tichanek, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

Survival in gastric and esophageal cancers in the Nordic countries through a half century
Yazar:: Kari Hemminki, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

Long-term survival trends for primary liver and pancreatic cancers in the Nordic countries
Yazar:: Kari Hemminki, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

Conditional survival in breast cancer up to 10 years in the Nordic countries
Yazar:: Frantisek Zitricky, ve diğerleri
Baskı/Yayın Bilgisi: (2023-09-01)

Survival trends in hematological malignancies in the Nordic countries through 50 years
Yazar:: Kari Hemminki, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01)

Survival improvements in esophageal and gastric cancers in the Nordic countries favor younger patients
Yazar:: Kari Hemminki, ve diğerleri
Baskı/Yayın Bilgisi: (2024-08-01)

High familial risks in some rare cancers may pinpoint to hidden germline genetics: focus on esophageal, stomach, small intestinal, testis, thyroid and bone cancers
Yazar:: Kari Hemminki, ve diğerleri
Baskı/Yayın Bilgisi: (2025-02-01)

Survival in oral and pharyngeal cancers is catching up with laryngeal cancer in the NORDIC countries through a half century
Yazar:: Frantisek Zitricky, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Age-specific familial risks in cancer as clues to germline genetic and environmental causes: focus on colorectal, endometrial, prostate, kidney, breast and lung cancers
Yazar:: Kari Hemminki, ve diğerleri
Baskı/Yayın Bilgisi: (2025-02-01)

Incidence, mortality and survival in multiple myeloma compared to other hematopoietic neoplasms in Sweden up to year 2016
Yazar:: Kari Hemminki, ve diğerleri
Baskı/Yayın Bilgisi: (2021-08-01)

Incidence and survival in non-hereditary amyloidosis in Sweden
Yazar:: Hemminki Kari, ve diğerleri
Baskı/Yayın Bilgisi: (2012-11-01)

Familial risks in and between stone diseases: sialolithiasis, urolithiasis and cholelithiasis in the population of Sweden
Yazar:: Kari Hemminki, ve diğerleri
Baskı/Yayın Bilgisi: (2018-07-01)

Rate differences between first and second primary cancers may outline immune dysfunction as a key risk factor
Yazar:: Guoqiao Zheng, ve diğerleri
Baskı/Yayın Bilgisi: (2020-11-01)

Epidemiology of Amyloidosis and Genetic Pathways to Diagnosis and Typing
Yazar:: Kari Hemminki, ve diğerleri
Baskı/Yayın Bilgisi: (2021-07-01)

Family history of any cancer for childhood leukemia patients in Sweden
Yazar:: Xinjun Li, ve diğerleri
Baskı/Yayın Bilgisi: (2021-08-01)

Survival in Thyroid Cancer in Sweden From 1999 To 2018
Yazar:: Zitricky F, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Second cancers and causes of death in patients with testicular cancer in Sweden.
Yazar:: Luyao Zhang, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01)

Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer
Yazar:: Riihimäki Matias, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Prostate cancer survivors: Risk and mortality in second primary cancers
Yazar:: Subhayan Chattopadhyay, ve diğerleri
Baskı/Yayın Bilgisi: (2018-11-01)

Surveillance Bias in Cancer Risk After Unrelated Medical Conditions: Example Urolithiasis
Yazar:: Kari Hemminki, ve diğerleri
Baskı/Yayın Bilgisi: (2017-08-01)

Survival in Lung Cancer in the Nordic Countries Through A Half Century
Yazar:: Tichanek F, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

Survival in common cancers defined by risk and survival of family members
Yazar:: Jianguang Ji, ve diğerleri
Baskı/Yayın Bilgisi: (2011-10-01)

Familial risks between Graves disease and Hashimoto thyroiditis and other autoimmune diseases in the population of Sweden
Yazar:: Hauke Thomsen, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

Second Primary Cancers After Kidney Cancers, and Kidney Cancers as Second Primary Cancers
Yazar:: Guoqiao Zheng, ve diğerleri
Baskı/Yayın Bilgisi: (2021-02-01)

Familial Associations of Colorectal Cancer with Other Cancers
Yazar:: Hongyao Yu, ve diğerleri
Baskı/Yayın Bilgisi: (2017-07-01)

Oncolytic viruses for cancer immunotherapy
Yazar:: Otto Hemminki, ve diğerleri
Baskı/Yayın Bilgisi: (2020-06-01)

The 'common disease-common variant' hypothesis and familial risks.
Yazar:: Kari Hemminki, ve diğerleri
Baskı/Yayın Bilgisi: (2008-01-01)

Oncolytic Immunotherapy: Where Are We Clinically?
Yazar:: Akseli Hemminki
Baskı/Yayın Bilgisi: (2014-01-01)

Portrait of a Leader in Immunotherapeutics<subtitle>Oncolytic viruses for treatment of cancer</subtitle>
Yazar:: Akseli Hemminki
Baskı/Yayın Bilgisi: (2012-08-01)

TILT Biotherapeutics
Yazar:: Akseli Hemminki
Baskı/Yayın Bilgisi: (2017-05-01)

Treatment of Advanced Renal Cell Carcinoma: Immunotherapies Have Demonstrated Overall Survival Benefits While Targeted Therapies Have Not
Yazar:: Otto Hemminki, ve diğerleri
Baskı/Yayın Bilgisi: (2020-12-01)

Are population level familial risks and germline genetics meeting each other?
Yazar:: Kari Hemminki, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)